期刊文献+

尿激酶脂质体对犬冠状动脉内血栓的加速溶栓作用 被引量:3

Accelerated thrombolysis by liposomal-encapsulatedurokinase in a canine model of acute myocardialinfarction
原文传递
导出
摘要 用之污剂清除技术制备尿激酶脂质体(LEUK),尿激酶(UK)包裹率25.6%。LEUK直径60.4±13.6nm,属中性大单层脂质体。在4℃缓冲液中贮存48h,UK渗漏率7.l%。LEUK、UK在37℃少含血小板血浆中孵化相同时间,LEUK组剩余UK活性百分率显著高于UK组(30分钟为:84.3±3D%,46±4%;60分钟为60±5%,14.9±0.8%。P<0.01)。提示脂质体能保护UK的纤溶能力,LEUK较UK半衰期延长一倍多。用凝血酶形成血栓后阻断动脉,建立犬急性冠状动脉内血栓模型,与UK进行溶栓对照研究(n=5)。结果LEUK组血管再通时间(28±7min)较UK组(69±7min,P<0.0l)缩短一倍多。剂量相应减小。溶栓后血中剩余纤维蛋白原LEUK织(2.5±0.5g/L)显著高于UK组(16±0.4,P<00l)。表明LEUK对加速溶栓减少出血并发症有实用价值。 e prepared liposomal-encapsulated urokinases(LEUK) by detergent removal technique. Theencapsulated efficiency of urokinase (UK) was 25.6% .The LEUKs were neutral large unilamellar vesiclesand its average diameter was 60.4±13.6 nm underelectron microscope. Measurements of UK activity in-dicated about 7.1% loss of activity or leakage intris-buffered saline over a 48 hr period at a tempera-ture of 4℃ . After the same time incubation of LEUKand UK in human platelet -poor plasma (PPP) at37℃, the pereentage of UK activity in LEUK groupwas remaining higher than that of UK group (30min:84.3 ±3.0% to 46± 4%; 60 min: 60±5% to 14.9 ±0.8%, P<0.0l). These results suggest that liposomespreserve the thrombolytic potential of UK and thatthe haif-life of UK in liposomes prolonges more thantwo times. Canine model of acute myocardialinfaretion was based on a thrombos obstruction.Thrombolysis tests were compared for LEUK and UK(n = 5). The time for restoring vessel patency redueedmore than 50% when compared with that in UKgroup (28 ±7 min to 69 ± 7 min, P<0.0l). The totaldosage of LEUK was correspondingly lower. Afterone-hour thrombolysis, the fibrinogen of LEUKgroup (g / L) was considerably higher than that of UKgroup (2.5 ± 0.5 to 1.6 ± 0.4, P<0.0l). These resultssuggested that LEUK may be of practical significancein accelerating thrombolysis and reduction in bleedingcomplications.
出处 《中华医学杂志》 CAS CSCD 北大核心 1994年第6期338-340,共3页 National Medical Journal of China
关键词 脂质体 冠状动脉 血栓形成 尿激酶 Liposome Urokinase CoronaryThrombosis Aninals, laboratory
  • 相关文献

参考文献3

  • 1黄惠民,中华血液学杂志,1992年,13卷,57页
  • 2团体著者,1989年
  • 3朱忠勇,临床医学检验(第2版),1978年

同被引文献24

  • 1周小波,何作云,苟小平,张艺.卡托普利改善主动脉缩窄高血压大鼠急性心肌损伤的实验研究[J].中国微循环,2004,8(4):221-224. 被引量:1
  • 2曹殿君,顾复生.卡托普利对犬实验性心肌梗塞的影响[J].中华心血管病杂志,1995,23(1):50-52. 被引量:7
  • 3[1]Karin Przyklenk and Robert A Kloner.Oxygen radical scavenging agents as adjuvant therapy with tissue plasminogen activator in a canine model of coronary thrombolysis[J].Cardiovascular Research,1993,27 (6):925-934.
  • 4[3]Hedblad B,Nilsson P,Engstrom G,et al.Insulin resistance in non-diabetic subjects is associated with increased incidence of myocardial infarction and death[J].Diabet Med,2002,19 (6):470-475.
  • 5[4]Brame L,Verma S,Anderson T,et al.Insulin resistance as a therapeutic target for improved endothelial function:metformin[J].Curr Drug Targets Cardiovasc Haematol Disord,2004,4(1):53-63.
  • 6[5]Yoshimura T,Hisatomi A,Kajihara S,et al.The relationship between insulin resistance and polymorphism of the endothelial nitric oxide synthase gene in patients with coronary artery disease[J].J Atheroscler Thromb,2003,10(1):43-47.
  • 7[6]Boulanger CM,Scoazec A,Ebrahimian T,et al.Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction[J].Circulation,2001,104(22):2649-2652.
  • 8[7]Gambhir KK,et al.Red blood cell insulin receptors in health and disease[J].Biochem Med Metab Biol,1991,45(2):133.
  • 9[8]Dodds K,Lamb P,Pentecost B,et al.Erythrocyte insulin receptors following myocardial infarction in non-diabetic subjects[J].Ann Clin Biochem,1986,23 (Pt 6):657-660.
  • 10Karin Przyklenk,Robert A Kloner.Oxygen radical scavenging agents as adjuvant therapy with tissue plasminogen activator in a canine model of coronary thrombolysis[J].Cardiovascular Research.1993,27:925~934

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部